Waverley Pharma Inc (WAVE) — Financial Flexibility Index
Latest as of September 2025:
-0.04x
Waverley Pharma Inc (WAVE) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of CA$-138.86K (operating CF CA$-138.86K minus capex CA$0.00) represents 0% of total liabilities (CA$3.64 Million).
Financial Flexibility Index
-0.04x
Free Cash Flow / Total Liabilities
Free Cash Flow
CA$-138.86K
Operating CF − Capex
Total Liabilities
CA$3.64 Million
CAD
Capital Expenditures
CA$0.00
CAD
Waverley Pharma Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Waverley Pharma Inc across 10 annual periods. See WAVE working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Waverley Pharma Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Waverley Pharma Inc. For the full company profile including market capitalisation, see market cap of Waverley Pharma Inc.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.10x | CA$-410.19K | CA$-410.19K | CA$4.08 Million | ▲ +79.4% |
| 2023 | -0.49x | CA$-1.02 Million | CA$-1.02 Million | CA$2.09 Million | ▼ -229.1% |
| 2022 | -0.15x | CA$-237.06K | CA$-237.06K | CA$1.60 Million | ▲ +64.8% |
| 2021 | -0.42x | CA$-798.78K | CA$-798.78K | CA$1.89 Million | ▼ -68.9% |
| 2020 | -0.25x | CA$-361.70K | CA$-361.70K | CA$1.45 Million | ▲ +72.6% |
| 2019 | -0.91x | CA$-1.41 Million | CA$-1.41 Million | CA$1.55 Million | ▲ +20.6% |
| 2018 | -1.15x | CA$-1.45 Million | CA$-1.45 Million | CA$1.26 Million | ▼ -1592.1% |
| 2017 | -0.07x | CA$-108.69K | CA$-108.69K | CA$1.60 Million | ▲ +99.3% |
| 2016 | -9.27x | CA$-108.69K | CA$-108.69K | CA$11.72K | ▲ +9.2% |
| 2015 | -10.21x | CA$-108.69K | CA$-108.69K | CA$10.65K | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities